Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wild Earth is a biotechnology company focused on reinventing pet food through sustainable, high-protein alternatives to traditional meat. Founded by biotech entrepreneur Ryan Bethencourt, the company utilizes fungal fermentation (specifically Aspergillus oryzae or Koji) and cellular agriculture to develop nutritionally complete dog food. Their products aim to reduce the environmental impact of the pet food industry while addressing common dietary sensitivities in pets. Wild Earth is also actively developing cell-based meat products specifically for the pet market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wild Earth.